Hyalofemme is now paraben free

hyalofemme new packIn spite of growing awareness of menopause, millions of women in the UK still suffer vaginal dryness in silence, and often in ignorance. Yet the problem is one of the easiest menopause symptoms to solve, with Hyalofemme, a vaginal moisturiser which is now available as a paraben-free formula.

Vaginal dryness – which causes pain especially during sex, itching, burning and an increase in vaginal infections – is common in menopause, after childbirth, as a result of medication especially for cancer, and at times of stress.

The consequences go beyond physical discomfort – it can interrupt daily functioning, create emotional and psychological distress, a sense of inadequacy and low self-esteem3.

“It’s fantastic that celebrities are talking about menopause and Kirsty Wark even made a documentary about it. We can talk about our hot flushes and even stress urinary incontinence because we can find ways to laugh about them, but vaginal dryness goes to the core of our womanhood so it’s harder to discuss and as a consequence millions of women aren’t asking for help,” says Dr Karen Gardiner, Managing Director of Purple Orchid, the women’s self-care company, which is the UK distributor of Hyalofemme.

And vaginal dryness gets worse over time – a study showed that 60% of women have symptoms after the fourth year of the menopause2.

Since more of us are living longer, it follows that the number of dry vaginas will increase.

For some women, the first sign of vaginal dryness (also known as vaginal atrophy, atrophic vaginitis and vulvo-vaginal atrophy) is discomfort or pain during sex. Because this is a difficult topic to discuss, as few as a quarter of women seek professional help3 or talk about it with their partners, and many relationships suffer as a result.

The pain, which arises when the dryness creates friction during movement, can lead to tiny cuts called microlesions, and it can become so severe that walking and exercise are painful. By solving the symptoms of vaginal dryness, Hyalofemme also improves quality of life and relationships.

Hyalofemme is an extremely effective vaginal moisturiser, made without hormones, perfumes and now without parabens too. Hyalofemme has been shown to be as effective as 0.1% local oestrogen therapy4 making it an excellent and economical alternative.

Hyalofemme is formulated with a unique, patented version of hyaluronic acid called Hydeal-D. Hyaluronic acid is well known as “nature’s moisturiser” because it occurs naturally throughout the body, lubricating joints and other areas as well as vaginal tissue, and it is also widely used in face creams.

Hydeal-D is special because it has a Low Molecular Weight, meaning it can cross the cell wall and deliver moisture inside the cells as well as adding moisture to the area generally, plumping cells up and restoring their elasticity5.

Its slow, long lasting release of water and its muco-adhesive properties mean that Hyalofemme stays in the vagina and needs to be used just once every three days, and many women can return to a spontaneous sex life without the need for a lubricant. Hyalofemme feels natural within the vagina and doesn’t cause the irritations that sometimes occur in such a sensitive area.

This is a completely different mode of action to a lubricant or moisturiser which simply introduces water or oil-based products into the vaginal cavity. There is scientific data to suggest that continued use of Hyalofemme can even reverse vaginal atrophy6.

Hyalofemme also promotes tissue repair to help heal microlesions and stimulates the body’s innate immune response to fend off potential infections7,8.

Hyalofemme is available on prescription and over the counter and is suitable for cancer patients and others for whom hormone therapy is not advised or desired. RRP £8.99 for 30g tube which is a month’s supply based on one dose every three days.



See www.hyalofemme.co.uk or Facebook/Twitter pages.

Hyalofemme is distributed in the UK by Purple Orchid, the Women’s Self-Care Company.



  • 1 Goldstein I, et al. Sex Med. 2013
  • 2 Dennerstein, Obstet Gynecol 2000
  • 3 Nappi RE, et al. Maturitas. 2016
  • 4 Chen J, et al
  • 5 Sandri, Journal of Pharmacy and Pharmacology, 2004
  • 6 Shuai-Bin Liu et al. 2014
  • 7 Dusio GF, et al. Immunol Cell Biol. 2011
  • 8 Gariboldi S, et al. J Immunol. 2008; 2103